F. Perry Wilson - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock F. Perry Wilson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
F. Perry Wilson
Verified
Director, Clinical and Translational Research Acc., Yale University School of Medicine and Columnist, Medscape
New Haven
Beats
Biography
Dr. Wilson grew up in Connecticut, before attending Harvard College where he graduated with honors in biochemistry. He then attended medical school at Columbia College of Physicians and Surgeons, before completing his internship, residency, and fellowship at the University of Pennsylvania. In 2012, he received a Masters degree in Clinical Epidemiology, which has informed his research ever since. At Yale since 2014, his goal is use patient-level data and advanced analytics to personalize medicine to each individual patient. To that end he holds multiple NIH grants and is the Director of Yale’s Clinical and Translational Research Accelerator. Dr. Wilson is internationally recognized for his expertise in design and interpretation of medical studies and has appeared in medpagetoday.com, medscape.com, the Huffington Post and the Milwaukee Journal Sentinel. His free online course, entitled "Understanding Medical Research: Your Facebook Friend Is Wrong" can be found on Coursera.org.
Clinical Trials, Social media, Methodology, Health Bias, Medicine
Content
By F. Perry Wilson| Medscape Verified This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson from the Yale School of Medicine. It’s quite a thing that we live in an era with the biggest blockbuster weight-loss drugs in history, and I can look at you straight-faced and say, yeah, but honestly that’s not the most interesting thing about the GLP-1 receptor agonists such as Ozempic.
By F. Perry Wilson| Medscape Noticias Médicas Verified Bienvenidos a Factor de Impacto, su dosis semanal de comentarios sobre un nuevo estudio en medicina. Soy el Dr. F. Perry Wilson, de la Yale School of Medicine, en New Haven, Estados Unidos. Un estudio tras otro sobre enfermedades, desde la enfermedad de Alzheimer hasta la infección por el virus del Zika, han demostrado que un nivel bajo de vitamina D es un factor de riesgo de desenlaces desfavorables.
By F. Perry Wilson| Medium@ April 1st, 2025. Irony has died. F. Perry Wilson, MD·Follow4 min read·--Ladies and gentlemen, it is April 1st. Under ordinary circumstances, I’d be bringing you something from the lighter side of medical research: a study about binge-watching Netflix and sleep deprivation or how swearing increases pain tolerance. But not today. That is because it is my grim duty to inform you that Irony has died. Please pardon my emotion as I attempt to make it through this obituary.
Company Info
Medscape